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Introduction: Intestinal failure is the consequence of diverse aetiologies and pathophysiological causes. Fistuloclysis is an 
effective means of nutritional support to selected intestinal failure patients. This study aimed to investigate the management of 
adult intestinal failure patients in hospitals in South Africa, determining how practical and acceptable fistuloclysis is.
Methods: The current management of type 2 and type 3 intestinal failure patients in South African hospitals was investigated by 
means of occupation-specific questionnaires, evaluating perceptions and opinions among dietitians.
Results: Twenty-seven dietitians indicated willingness to participate in the survey, the majority (67%) having been involved 
with patient management in this field for one to five years. All indicated correctly that high fistula outputs would be defined as 
intestinal failure. Only 47% gave the correct definition of fistuloclysis, while 28% were currently utilising it as a means of nutrition 
support. All respondents agreed that unsuccessful implementation of fistuloclysis was due to training shortfalls and resistance 
from clinicians and nursing staff.
Conclusion: There is a positive perception and awareness of fistuloclysis; however, numerous stumbling blocks hamper the 
wider use of this novel treatment.
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Introduction
Intestinal failure (IF), its complications and costs associated with 
parenteral nutrition (PN) support in this particular patient 
population are a reality in the South African context. Owing to 
the nature and complexity of IF, long-term hospitalisation and 
PN support to improve or maintain nutritional status is often 
required to, allow enough time between surgical interventions, 
and time to treat pre-existing complications, before a patient can 
be considered for definitive surgery.1,2
Fleming and Remington first defined the concept of IF in 1981 as 
‘a reduction in the functional gut mass below the minimal 
amount necessary for adequate digestion and absorption of 
food’.3−5 This definition of IF has since been revised by other 
authors to include, among others, duration, stage, degree of 
impairment and underlying causes. In 2014, the European Society 
for Clinical Nutrition and Metabolism (ESPEN) published 
recommendations on the definition and classification of IF in 
adults. According to the ESPEN classification, IF can be defined as 
‘the reduction of gut function below the minimum necessary for 
absorption of macronutrients and/or water and electrolytes, such 
that intravenous (IV) supplementation is required to maintain 
health and/or growth’.3 The need for IV replacement of nutrients 
and/or fluids is used as a surrogate marker for the diagnosis of IF 
in the absence of readily available complex metabolic studies.3,6
Micronutrients are not included in the definition, and 
micronutrient deficiencies alone due to gut impairment are not 
classified as IF. In situations where the absorptive ability of the 
gut is impaired, but not to the degree that IV supplementation of 
fluid and/or nutrients is required to maintain health and growth, 
the condition can be referred to as ‘intestinal insufficiency’.3 IF 
has been sub-divided into three types based on the onset and 
expected metabolic impact and outcome.3,7,8 Type 1 IF is usually 
self-limiting, short term and often perioperative.9−11 Common 
causes of type 1 IF include mechanical intestinal obstruction and 
non-mechanical ileus.10 Type 1 IF usually resolves within seven to 
14  days with conservative management and nasogastric 
drainage, and might require short-term PN support.10,12 Type 2 IF 
is a serious condition associated with a higher incidence of 
mortality.3,10 Patients usually develop type 2 IF as a result of 
complications of abdominal surgery leading to abdominal sepsis 
and intestinal fistulation.10 An estimated 10% of patients will also 
have significant reduction in intestinal length at the time of 
diagnosis.10 Type 2 IF is usually not self-limiting, with the 
exception of patients with simple intestinal fistulation where 
spontaneous closure may occur with effective nutritional and 
medical support.10 Type 3 IF refers to a chronic condition in a 
metabolically stable patient, requiring long-term PN support, 
often for years, with careful monitoring for complications.3,9,11
Fistuloclysis, i.e. feeding of intestinal effluent via a distal intestinal 
fistula or stoma, is an effective and feasible way of managing 
patients with IF and is often the only alternative to long-term PN 
support.13,14 Enteral nutrition (EN), apart from being less costly, 
has considerable advantages over PN support.15 The advantages 
include improved gut barrier function, reduction in infectious 
morbidity and improved immune function.15
In a resource-scarce environment, there is a need to explore 
novel treatment options that are effective in promoting the 
medical and nutritional status of patients, while minimising risk, 
improving quality of life and reducing cost. Fistuloclysis is a 
feasible, but underutilised, option for the management of IF in 
the South African context. The motivation for this study was to 
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collect information regarding the management of IF as well as 
the opinion and perceptions of dietitians regarding fistuloclysis. 
This information will be useful in terms of establishing equipment 
and training needs and the readiness of institutions to adapt to a 
novel nutritional management solution.
Methods
Study population
Dietitians working in South Africa who are currently involved in the 
nutritional management of IF patients were eligible for inclusion. 
Although it was anticipated that the number of dietitians that 
meet the above-mentioned criterion would be relatively small 
(mainly those associated with tertiary and maybe secondary 
hospitals, as well as private practicing dietitians associated with 
private hospitals), it was not possible to predict the exact number 
as no such register exists. Since the principal investigator is 
responsible for the nutritional management of IF patients at 
Groote Schuur Hospital, the latter institution was excluded.
Study design and methods
A descriptive observational study of the current management of 
IF patients in South African hospitals, as well as of the perceptions 
and opinions of dietitians about fistuloclysis as a treatment 
option for IF was done by means of a self-administered 
questionnaire.
Figure 1: Flow chart indicating participation in study.
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The questionnaire was developed in consultation with professionals 
currently involved in the management of IF patients in Groote 
Schuur Hospital where fistuloclysis had been implemented 
successfully. The questionnaire was validated for face and content 
validity and underwent interdisciplinary review. Minor adaptations 
were made accordingly. The web-based system, Survey Monkey, 
was used to manage the survey. The inclusion criterion was 
dietitians currently involved in the management of IF patients in 
South African hospitals other than Groote Schuur Hospital. In an 
attempt to adhere to the inclusion and exclusion criteria, questions 
were built into the questionnaire that would exit the respondents 
from the survey early if they did not fit the criteria. An example of 
such a question was ‘Are you currently involved in the management 
of intestinal failure patients?’, and if the respondent answered ‘no’, 
they were exited from the questionnaire. If respondents did fit the 
inclusion criteria but were not familiar with the term fistuloclysis, 
they were given a brief explanation and allowed to continue with 
the survey. The survey took approximately 15 min to complete.
The survey was advertised via the Association for Dietetics in South 
Africa (ADSA) and the South African Society for Parenteral and 
Enteral Nutrition (SASPEN), since many registered dietitians 
(around 60–65%) in South Africa belong to either of these 
organisations. An email containing a link to the Survey Monkey 
questionnaire was distributed via the mailing lists of ADSA and 
SASPEN to recruit dietitians for participation (N = ±1800). A second 
email was sent out two weeks after the first as a reminder. The 
survey remained open for completion for a total of four weeks.
Statistical analysis
The data obtained from Survey Monkey were downloaded in the 
form of an Excel spreadsheet. The data were analysed by the 
principal investigator using Microsoft Excel and reported as 
descriptive statistics.
Ethics
Ethics approval was obtained from the Stellenbosch University 
Health Research Ethics Committee (Reference # S14/09/177).
Questionnaires were completed anonymously through Survey 
Monkey and willingness to participate in the study was regarded 
as informed consent. Standard to any research study, participants 
had the opportunity to exit the study at any time if they so 
wished, without providing reasons for doing so.
Results
A flowchart depicting the participating in the study is displayed 
in Figure 1. Twenty-seven dietitians indicated willingness to 
participate in the survey. As can be seen from Figure 1, there was 
almost a 50:50 split between participation from the public and 
private sectors with the majority of respondents from the public 
sector being in secondary or tertiary healthcare institutions.
Six respondents were excluded from the survey since they were 
not directly involved in the nutritional management of IF patients 
in their current practices, thus not meeting the primary inclusion 
criteria of the study. The years of experience in the field of IF of 
the 21 respondents that continued with the survey are displayed 
in Figure 2. The majority of respondents, i.e. 67% (n = 14/21), had 
been involved with patient management in this field for one to 
five years.
Respondents were given eight options of clinical conditions or 
clinical presentations, and asked to indicate which of these they 
would regard as IF (a choice for ‘more than one’ option was 
provided) (Figure 3). Only 18 out of 21 respondents answered 
this question and continued with the survey (Figure 1). All the 
respondents indicated that high fistula outputs (n = 18/18, 100%) 
would be defined as IF, while ileus (n = 11/18, 61%), short bowel 
syndrome (n  = 12/18, 67%) and bowel obstruction (n  = 14/18, 
78%) were also often indicated as IF.
Seventeen respondents continued with the survey to answer the 
section on fistuloclysis knowledge. This section contained an 
open-ended question where respondents had to explain their 
understanding of the term fistuloclysis. The majority (n = 9/17, 
53%) could not provide a correct explanation. Majority of those 
who provided the correct interpretation of the term fistuloclysis 
[47%; (n  = 8/17)] were employees in public sector tertiary 
hospitals (n = 4/8, 50%), followed by equal representation from 
public sector secondary (n  = 2/8, 25%) and private hospitals 
(n = 2/8, 25%).
Another three participants exited the study and only fourteen 
responded to the question on whether they had ever used 
fistuloclysis before in their current or previous settings. This 
section consisted of closed and open-ended questions. Of the 
fourteen participants, 43% (n  = 6/14) had used it before, 28% 
(n = 4/14) were using fistuloclysis in their current settings and, 
similarly, 28% (n = 4/14) had never used it as a treatment method. 
Interestingly, 50% of respondents who were familiar with the 
term and could provide a correct description in the previous 
section, had never used fistuloclysis as a treatment method. The 
current users were spread between the public sector in secondary 
hospitals (n = 2/4, 50%) and tertiary institutions (n = 1/4, 25%) 







































Figure 3: Conditions regarded as intestinal failure by respondents.
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Figure 3: Conditions regarded as intestinal failure by respondents.
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health professionals working with IF patients, it was not possible 
to identify relevant dietitians for targeted sampling.
South African statistics on the incidence of IF are not available. 
Data from hospitals in England indicate that the incidence of IF is 
in the region of 18 per million of the population per year; this was 
based on patients receiving PN support for at least 14 days.10 If 
this were to be extrapolated to the South African context, the 
number of such patients would amount to roughly 970 patients 
per year, out of a population of around 55 million. It could 
therefore be postulated that the number of dietitians working in 
the field of clinical dietetics and who manage IF patients is quite 
limited. This may be the reason for the small number of responses 
received. There was good representation within the 27 
participants of the public as well as private healthcare sectors. 
Most participants from the public setting were involved in care at 
secondary and tertiary level where management of IF patients is 
expected.
A diverse number of clinical conditions all resulting in either 
increased losses and decreased absorption of nutrients were 
regarded as IF by participating dietitians. This is in line with the 
definition of IF provided by ESPEN who classifies IF according to 
a functional and pathophysiological classification.3 The 
pathophysiological classification includes five primary 
pathologies: short bowel syndrome (SBS), intestinal fistula, 
intestinal dysmotility, mechanical obstruction and extensive 
small bowel mucosal disease.3
When asked to indicate conditions that can be regarded as IF, 
67% of the respondents indicated that they associate SBS with IF. 
SBS could result from extensive surgical resection due to a 
number of indications or as a result of congenital disease of the 
small intestine.3,16−18 The pathophysiological manner in which 
SBS causes IF is due to extensive loss of absorptive surface 
area.3,19 SBS is the leading cause of type 3 IF and accounts for 
around 75% of adults receiving home parenteral nutrition (HPN) 
in Europe.3
Intestinal fistula is defined as an abnormal communication 
between two epithelium-lined surfaces.2,3,13,20−22 Classification of 
fistulae can be done on the basis of the anatomy, physiology or 
aetiology.13,21−24 The physiological classification for fistulae is based 
on output and defines less than 200  ml per day as low output, 
while 200–500 ml per day is classified as moderate output. 3,22−25 
Effluent of  >  500  ml per day in the fasted state is considered a 
high-output fistula. 3,20,22,23,25 The most common cause of intestinal 
fistulae are surgical complications, amounting to 75–85% of 
cases.3,13,20,23,24,26−28 The remaining 15–25% of fistulae arise from the 
underlying pathology, with Crohn’s disease being a major 
contributor.3,27,28 The pathophysiological manner in which fistulae 
cause IF is by the loss of enteric content through a proximal 
opening or by bypassing a significant segment of gut in the case 
of internal entero-enteric fistulae.3,21,29 All respondents agreed and 
indicated that a high-output fistula is associated with IF.
The term intestinal dysmotility refers to the presence of a 
disorder that impairs the propulsion of gut content in the 
absence of an obstruction.3 Intestinal dysmotility can present as 
type 1 IF in the case of acute postoperative ileus or critical illness 
associated ileus.3 Dysmotility often presents as a result of 
systemic or intra-abdominal inflammation as type 2 IF.3 Chronic 
IF associated with dysmotility is referred to as chronic intestinal 
pseudo-obstruction (CIPO) with the ‘pseudo’ indicating the 
absence of an occluding lesion.3 The primary pathophysiology in 
they had only used it on one or two patients in the preceding 
two years and did not have much experience with it. Three of the 
four (n  = 3/4, 75%) currently using fistuloclysis thought that it 
was a practical and achievable option for nutrition support. One 
respondent said ‘If it is something that is effective then it would be 
great if it became more common practice. I must admit I have not 
researched it but will definitely after this survey.’ The three 
respondents also indicated that patients experienced fistuloclysis 
as an acceptable mode of nutrition support. One volunteered 
comment was: ‘Our patient actually preferred it to the TPN [Total 
Parenteral Nutrition]. She found the TPN catheter site very 
uncomfortable’.
PN was indicated as the treatment modality most commonly 
used in institutions where fistuloclysis was not done or when 
fistuloclysis was not possible for an individual patient. In those 
cases, PN was used either as a first line treatment early in the 
management course, or reverted to if other methods like EN or 
oral intake failed. Failing of enteral or oral nutrition seemed to be 
regarded as an increase in output from the stoma or fistula above 
a tolerable level.
Respondents were given five common stumbling blocks for the 
successful implementation of fistuloclysis and were asked to 
indicate which of the five options were applicable in their 
opinion/institution. All the respondents agreed (Figure 4) that 
lack of training (n = 12/12, 100%) contributed to the unsuccessful 
implementation of fistuloclysis in their institutions. The second 
most prevalent reason was perceived as resistance from clinicians 
and nursing staff (n  = 9/12, 75%), with lack of equipment 
(n = 7/12, 58%) ranking third.
All respondents agreed that they would consider fistuloclysis as 
a method of nutritional support if they had more information 
and a protocol available to guide the process.
Discussion
This study was the first in South Africa that attempted to 
determine the opinions of dietitians on fistuloclysis as a 
treatment option for the management of IF patients. Few 
dietitians (47%) knew the correct definition of fistuloclysis, with 
an even smaller number (28%) currently utilising it as a means of 
nutrition support.
A major limitation of the study is the small participation rate. This 
was partly expected since an inclusion criterion was for the 
dietitians to be currently working with the nutritional 
management of IF patients. The latter would only be admitted to 
tertiary or some secondary public-sector hospitals, or 















Figure 4: Reasons identified for unsuccessful implementation of 
fistuloclysis.
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Nutrition support via the PN route was indicated as the route of 
choice most often used by respondents, either as a first line 
treatment or after enteral or oral nutrition had failed. Respondents 
indicated that they regarded enteral or oral nutrition to be 
unsuccessful if they experienced an increase in the fistula or stoma 
output. In the case of IF, the preferred mode of nutrition delivery 
would depend largely on the underlying cause, and the responses 
could be regarded as in accordance with evidence-based 
guidelines. All SBS patients will require PN support in the 
immediate postoperative phase to maintain nutritional status.30 
SBS with permanent PN dependence is strongly related to a small 
bowel length of < 50 cm post duodenum and to the absence of 
ileum and/or colon in continuity.31 Values separating transient and 
permanent IF differ according to anatomy and are 100 cm for an 
end-enterostomy, 65 cm for a jejunocolic anastomosis and 30 cm 
for a jejunoileocolic anastomosis.31 Bowel adaptation usually 
occurs within the first two years following the last surgical 
intervention.18,19,30 The degree of adaptation is related to the 
extent of the resection as well as the anatomy of the remnant 
bowel.18,32,33 Structural and functional changes occur in the 
remnant bowel that improves nutrient and fluid absorption.18,19,32,33 
Adaptation after two years is uncommon and limited to a 
maximum improvement of 5–10% in absorptive capacity.30 In the 
case of fistulae, enteral nutrition support is the preferred route of 
nutrition support, unless it increases fistula output significantly or 
causes increased abdominal pain or exacerbates diarrhoea.4,20,26 
Bowel absorptive capacity should be sufficient for successful 
implementation of enteral nutrition support, and patients with 
fistulae should be able to tolerate polymeric enteral formula, 
unless a patient has less than 120 cm of bowel left, has documented 
intolerance to polymeric enteral feed, or experiences high fistula 
output.21,25 In that case, the patient should be changed to a semi-
elemental or elemental enteral product.25 The literature suggests 
that absolute contraindications to enteral nutrition include bowel 
discontinuity or insufficient bowel length, usually  <  75  cm.13,25 
This, however, might not be an absolute in practice. In the case of 
intestinal dysmotility and bowel obstruction PN would be 
indicated as the primary route of nutrition support.3 The same 
would apply in the case of extensive small bowel mucosal disease, 
where intestinal nutrient absorption is completely impaired and 
the enteral or oral route becomes futile.3
Conclusion and recommendations – Acknowledging the small 
participation rate, we can confirm that the employment of 
fistuloclysis in the management of adult IF patients in South 
African hospitals is underutilised. It is, however, evident that the 
dietitians that responded were positive about the concept of 
fistuloclysis and were willing to apply it in patient care. Since all 
respondents indicated that they would consider using 
fistuloclysis as a means of nutrition support if they could gain the 
knowledge through training and had protocols available to 
guide the process, we can safely say that lack of training has 
been identified as a big stumbling block in the successful 
implementation of fistuloclysis. This could be addressed through 
training and protocol development. Nursing and clinician 
resistance have been identified as other potential stumbling 
blocks in the implementation of fistuloclysis. Therefore, the 
training and protocols should include these health professionals 
as they play a pivotal role in the successful execution thereof.
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intestinal dysmotility that gives rise to IF is the intolerance to oral 
or enteral nutrition, resulting in inadequate nutrient intake.3 The 
mucosal surface is generally preserved.3 Causes of IF correctly 
indicated by respondents that could be classified as intestinal 
dysmotility included ileus (61%), vomiting (28%) and high 
nasogastric output (33%)
Mechanical obstruction refers to a physical abnormality affecting 
the intestine.3 This could be intraluminal (e.g. foreign bodies), 
intrinsic (e.g. stenosis), or extrinsic (e.g. frozen abdomen).3 
Furthermore, these might be of benign or malignant origin.3 It 
could present as a type 1 IF, which presents acutely and resolves 
within days with conservative management or surgery. It might 
also present as a type 2 or 3 IF with a prolonged course.3 The 
pathophysiological mechanism of IF due to mechanical 
obstruction is the spontaneous or prescribed ceasing of oral 
intake.3 Vomiting and high nasogastric output, indicated by 
respondents as causes for IF, could also be the clinical manifestation 
of bowel obstruction. Furthermore, bowel obstruction per se was 
indicated as a cause of IF by 78% of respondents.
Extensive small bowel mucosal disease refers to a condition 
where there is intact or almost intact but inefficient mucosal 
surface.3 There is a reduction in nutrient absorption and/or an 
increase in nutrient loss via the mucosa to the point where the 
nutritional needs cannot be met, e.g. coeliac disease, radiation 
enteritis and protein-losing enteropathy.3 Chronic diarrhoea was 
correctly indicated as IF by 56% of respondents.
Only 47% of respondents were familiar with the term fistuloclysis 
and could give a correct explanation, with the majority of them 
currently working in tertiary hospitals. Despite the fact that 
fistuloclysis is successfully implemented internationally,15 we 
could find no literature which specifically evaluates the knowledge 
and practices of the multidisciplinary team with regard to 
fistuloclysis to which our findings could be compared. This study 
therefore adds useful information to identify gaps and barriers in 
the implementation of fistuloclysis in the South African context.
Of interest was the number (50%) of respondents who were 
familiar with the term fistuloclysis but had never used it before. 
This is a positive finding since it indicates awareness concerning 
fistuloclysis. Since training and resistance from nursing staff and 
clinicians were indicated as the two leading reasons for 
unsuccessful implementation of fistuloclysis, awareness could 
potentially be turned into practice through appropriate training 
and advocacy. It would also have been valuable to have had 
sufficient information available regarding the opinions and 
perceptions of nursing staff and doctors on fistuloclysis, as this 
would have provided a more comprehensive picture regarding 
the management of these complex surgical cases.
Although six out of 14 respondents had used fistuloclysis in 
practice before, only four were using the method at that time, but 
indicated it was not a regular procedure in their institutions. 
Surprisingly, two of the four respondents using fistuloclysis at that 
time were situated in secondary hospitals within the public sector. 
This was an unexpected finding, since the assumption based on 
current practice was that patients with IF would be managed at 
tertiary level. It is encouraging that fistuloclysis can be successfully 
implemented at this level. The respondents did indicate that this 
was not the norm for nutritional management at their institution 
and that it had only been done in respect of one or two patients 
over a two-year period. All the dietitians who had used it before 
found it to be successful and well received by patients.
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choice most often used by respondents, either as a first line 
treatment or after enteral or oral nutrition had failed. Respondents 
indicated that they regarded enteral or oral nutrition to be 
unsuccessful if they experienced an increase in the fistula or stoma 
output. In the case of IF, the preferred mode of nutrition delivery 
would depend largely on the underlying cause, and the responses 
could be regarded as in accordance with evidence-based 
guidelines. All SBS patients will require PN support in the 
immediate postoperative phase to maintain nutritional status.30 
SBS with permanent PN dependence is strongly related to a small 
bowel length of < 50 cm post duodenum and to the absence of 
ileum and/or colon in continuity.31 Values separating transient and 
permanent IF differ according to anatomy and are 100 cm for an 
end-enterostomy, 65 cm for a jejunocolic anastomosis and 30 cm 
for a jejunoileocolic anastomosis.31 Bowel adaptation usually 
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case of fistulae, enteral nutrition support is the preferred route of 
nutrition support, unless it increases fistula output significantly or 
causes increased abdominal pain or exacerbates diarrhoea.4,20,26 
Bowel absorptive capacity should be sufficient for successful 
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fistulae should be able to tolerate polymeric enteral formula, 
unless a patient has less than 120 cm of bowel left, has documented 
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output.21,25 In that case, the patient should be changed to a semi-
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that absolute contraindications to enteral nutrition include bowel 
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This, however, might not be an absolute in practice. In the case of 
intestinal dysmotility and bowel obstruction PN would be 
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would apply in the case of extensive small bowel mucosal disease, 
where intestinal nutrient absorption is completely impaired and 
the enteral or oral route becomes futile.3
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